L-carnitine ameliorates immunological-induced hepatitis in rats

Saudi Pharmaceutical Journal

Volumn 14, Issue 1, 2006, Pages 59-68

  Abd Allah, Adel R A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Immunological hepatitis; L carnitine; LPS

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CARNITINE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; LIVER ENZYME; MALONALDEHYDE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DRUG MECHANISM; HEPATITIS; IMMUNITY; LIVER; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SURVIVAL RATE; TISSUE DISTRIBUTION;

EID: 33644501497     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Yokoyama M, Yokoyama A, Mori S, Takahashi HK, Yoshino T, Watanabe T, Watanabe T, Ohtsu H, Nishbori M. Inducible histamine protects mice from P. acnes-primed and LPS-induced hepatitis through H2-receptors stimulation. Gartroinrtol, 2004; 127(3):892-902.
2. Suntres ZE. Prophylaxis against lipopolysacchride-induced liver injuries by lipoic acid in rats. Pharmacol Res, 2003; 48(60):585-591.
3. Kiemer AK, Muller C, Vollmar AM. Inhibition of LPS-induced nitric oxide and TNF-alpha production by alpha-lipoic acid in rat Kupffer cells and in RAW 264.7 routine macrophages. Immunol Cell Biol. 2002; 80(6):550-557.
4. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem, 1990; 192: 245-261.
5. Edwards MJ, Keller BJ, Kauffman FC, Thrman RG. The involvement of Kupffer cells in carbon tertrachloride toxicity. Toxicol Appl Pharmacol, 1993; 119:275-279.
6. Thiemermann C, rutten H, Wu CC, vane JR. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibition of nitric oxide sunthase. Br J Pharmacol, 1995; 116(7):2845-2851.
7. Kinoshita M, Uchida T, Nakashima H, Ono S, Seki S, hiraide H. Opposite effect of enhanced tumor necrosis factor-alpha production from Kupffer cells by gadolinium chloride on liver injuries/mortality in endotoxemia of normal and partially hepatectomized mice. Shock 2005; 23(1):65-72.
8. Wang H, Wei W, Zhang SY, Shen YX, Yue L, Wang NP, Xu SY. Melatonin-selenium nanoparticles inhibit oxidative stress and protect against hepatic injury induced by Bacillus Calmette-Guerin/lipopolysaccharide in mice. J Pineal Res. 2005; 39(2):156-63. 26.
9. Mancuso G, Midiri A, Biondo C, Beninati C, Gambuzza M, Macri D, Bellantoni A, Weintraub A, Espevik T, Teti G. Bacteroides fragilis-Derived Lipopolysaccharide Produces Cell Activation and Lethal Toxicity via Toll-Like Receptor 4. Infect Immun. 2005; 73(9):5620-7.
10. Fletcher MA, McKenna TM, Quance JL, Wainwright NR, Williams TJ. Lipopolysaccharide detoxification by endotoxin neutralizing protein. J Surg Res. 1993; 55(2):147-54.
11. Goa KL, Brogden RN. l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeuticuse in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism. Drugs. 1987; 34(1):1-24.
12. Athanassakis I, Mouratidou M, Sakka P, Evangeliou A, Spilioti M, Vassiliadis S. L-carnitine modifies the humoral immune response in mice after in vitro or in vivo treatment, Int Immunopharmacol. 2001; 1(9-10):1813-22.
13. Mosca L, Marcellini S, Perluigi M, Mastroiacovo P, Moretti S, Famularo G, Peluso I, Santini G, De Simone C. Modulation of apoptosis and improved redox metabolism with the use of a new antioxidant formula. Biochem Pharmacol. 2002 1; 63(7):1305-14.
14. Arockia Rani PJ, Panneerselvam C. Carnitine as a free radical scavenger in aging. Exp Gerontol. 2001; 36(10):1713-26.
15. Andrieu-Abadie N, Jaffrezou JP, Hatem S, Laurent G, Levade T, Mercadier JJ. L-carnitine prevents doxorubicin-induced apoptosis of cardiac myocytes: role of inhibition of ceramide generation. FASEB J. 1999; 13(12):1501-10.
16. Miguez MP, Soler F, Garcia-Rubio L. Accentuation of paraquat-induced toxicity by L-carnitine in mice. Biofactors. 1998; 8(1-2):73-8.
17. Arafa HM, Abd-Allah AR, El-Mahdy MA, Ramadan LA, Hamada FM. Immunomodulatory effects of L-carnitine and q10 in mouse spleen exposed to low-frequency high-intensity magnetic field. Toxicology. 2003 3; 187(2-3):171-81.
18. Ramadan LA, Abd-Allah AR, Aly HA, Saad-el-Din AA. Testicular toxicity effects of magnetic field exposure and prophylactic role of coenzyme Q10 and L-carnitine in mice. Pharmacol Res. 2002; 46(4):363-70.
19. Deufel T. Determination of L-carnitine in biological fluids and tissues. J Clin Chem Clin Biochem. 1990; 28(5):307-11.
20. Reed LJ and Muench H. A simple method of estimating fifty per cent end point. Am J Hyg. (1938); 27:493-499.
21. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82(1):70-7.
22. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95(2):351-8.
23. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide. 2001; 5(1):62-7.
24. Kasai H, Crain PF, Kuchino Y, Nishimura S, Ootsuyama A, Tanooka H. Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. Carcinogenesis. 1986; 7(11):1849-51.
25. McHeyzer-Williams MG. Combinations of interleukins 2, 4 and 5 regulate the secretion of murine immunoglobulin isotypes. EurJ Immunol. 1989; 19(11):2025-30
26. Green RM and Flamm S. Technical review of evaluation of liver chemistry test. Gastroentrology 2002; 123:1367-1384
27. Reichling JJ and Kaplan MM. Clinical use of serum enzymes in liver disease. Dig Dis Sci. 1988; 33:1601-1604
28. Szasz G. A kinetic photometric method for serum gamma-glutamyl transpeptidase. Clin Chem. 1969; 15(2):124-36.
29. Proudfoot AE, Power CA, Wells TN. The strategy of blocking the chemokine system to combat disease. Immunol Rev. 2000; 177:246-56.
30. Kunkel SL. Through the looking glass: the diverse in vivo activities of chemokines. J Clin Invest. 2000; 105(11):1515-7.
31. Speyer CL, Gao H, Rancilio NJ, Neff TA, Huffnagle GB, Sarma JV, Ward PA. Novel chemokine responsiveness and mobilization of neutrophils during sepsis. Am J Pathol. 2004; 165(6):2187-96.
32. Zisman DA, Kunkel SL, Stricter RM, Tsai WC, Bucknell K, Wilkowski J, Standiford TJ. MCP-1 protects mice in lethal endotoxemia. J Clin Invest. 1997; 99(12):2832-6.
33. Gui SY, Wei W, Wang H, Wu L, Sun WY, Wu CY. Protective effect of fufanghuangqiduogan against acute liver injury in mice. World J Gastroenterol. 2005; 11(19):2984-9.
34. Luyendyk JP, Copple BL, Barton CC, Ganey PE, Roth RA. Augmentation of aflatoxin B1 hepatotoxicity by endotoxin: involvement of endothelium and the coagulation system. Toxicol Sci. 2003; 72(1):171-81.
35. Barton CC, Barton EX, Ganey PE, Kunkel SL, Roth RA. Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor alpha. Hepatology. 2001; 33(1):66-73.
36. Scherer MN, Graeb C, Tange S, Dyson C, Jauch KW, Geissler EK. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats. Hepatology. 2000; 32(5):999-1007.
37. Sayed-Ahmed MM, Eissa MA, Kenawy SA, Mostafa N, Calvani M, Osman AM. Progression of cisplatin-induced nephrotoxicity in a carnitine-depleted rat model. Chemotherapy. 2004; 50(4):162-70.
38. Takeyama N, Takagi D, Matsuo N, Kitazawa Y, Tanaka T. Altered hepatic fatty acid metabolism in endotoxicosis: effect of L-carnitine on survival. Am J Physiol. 1989; 256(1 Pt 1):E31-8.
39. Hassan MI, Ahmed MI, Kassim SK, Rashad A, Khalifa A. Cis-platinum-induced immunosuppression: relationship to melatonin in human peripheral blood mononuclear cells. Clin Biochem. 1999; 32(8):621-6.
40. Winterboura CC, Peskin AV, Parsons-Mair HN. Thiol oxidase activity of copper, zinc superoxide dismutase. J Biol Chem. 2002; 277(3):1906-11.
41. Inoue M, Sato EF, Nishikawa M, Park AM, Kira Y, Imada I, Utsumi K. Cross talk of nitric oxide, oxygen radicals, and superoxide dismutase regulates the energy metabolism and cell death and determines the fates of aerobic life. Antioxid Redox Signal. 2003; 5(4):475-84.
42. Calabrese V, Scapagnini G, Ravagna A, Bella R, Butterfield DA, Calvani M, Pennisi G, Giuffrida Stella AM. Disruption of thiol homeostasis and nitrosative stress in the cerebrospinal fluid of patients with active multiple sclerosis: evidence for a protective role of acetylcarnitine. Neurochem Res. 2003; 28(9):1321-8.
43. Arafa HM, Sayed-Ahmed MM. Protective role of carnitine esters against alcohol-induced gastric lesions in rats. Pharmacol Res. 2003; 48(3):285-90.
44. Kiziltunc A, Cogalgil S, Cerrahoglu L. Carnitine and antioxidants levels in patients with rheumatoid arthritis. Scand J Rheumatol. 1998; 27(6):441-5.
45. Atroshi F, Biese I, Saloniemi H, Ali-Vehmas T, Saari S, Rizzo A, Veijalainen P. Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice. J Pharm Pharm Sci. 2000; 3(3):281-91.
46. Kiemer AK, Hartung T, Huber C, Vollmar AM. Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kappaB pathway. J Hepatol. 2003; 38(3):289-97.
47. Loft S, Thorling EB, Poulsen HE. High fat diet induced oxidative DNA damage estimated by 8-oxo-7, 8-dihydro-2-deoxyguanosine excretion in rats. Free Radic Res. 1998; 29(6):595-600.
48. Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR Jr, Lee DH. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med. 2004; 37(7):1018-23.
49. Abd-Allah AR, Al-Majed AA, Al-Yahya AA, Fouda SI, Al-Shabana OA. L-Carnitine halts apoptosis and myelosuppression induced by carboplatin in rat bone marrow cell cultures (BMC). Arch Toxicol. 2005; 79(7):406-13.
50. Yoon HR, Hong YM, Boriack RL, Bennett MJ. Effect of L-carnitine supplementation on cardiac carnitine palmitoyltransferase activities and plasma carnitine concentrations in adriamycin-treated rats. Pediatr Res. 2003; 53(5):788-92.
51. Czeczot H, Scibior D. [Role of L-carnitine in metabolism, nutrition and therapy] Postepy Hig Med Dosw (Online). 2005; 59:9-19.
52. Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N Y Acad Sci. 2004; 1033:30-41.
53. Shankar SS, Mirzamohammadi B, Walsh JP, Steinberg HO. L-carnitine may attenuate free fatty acid-induced endothelial dysfunction. Ann N Y Acad Sci. 2004; 1033:189-97.